Cancel anytime
PACS Group, Inc. (PACS)PACS
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/18/2024: PACS (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Upturns
Type: Stock | Upturn Star Rating | Today’s Advisory: Consider higher Upturn Star rating |
Profit: 22.97% | Upturn Advisory Performance 5 | Avg. Invested days: 45 |
Profits based on simulation | Stock Returns Performance 3 | Last Close 09/18/2024 |
Type: Stock | Today’s Advisory: Consider higher Upturn Star rating |
Profit: 22.97% | Avg. Invested days: 45 |
Upturn Star Rating | Stock Returns Performance 3 |
Profits based on simulation Last Close 09/18/2024 | Upturn Advisory Performance 5 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 6.32B USD |
Price to earnings Ratio 66.75 | 1Y Target Price 41 |
Dividends yield (FY) - | Basic EPS (TTM) 0.61 |
Volume (30-day avg) 803458 | Beta - |
52 Weeks Range 22.61 - 42.25 | Updated Date 09/15/2024 |
Company Size Mid-Cap Stock | Market Capitalization 6.32B USD | Price to earnings Ratio 66.75 | 1Y Target Price 41 |
Dividends yield (FY) - | Basic EPS (TTM) 0.61 | Volume (30-day avg) 803458 | Beta - |
52 Weeks Range 22.61 - 42.25 | Updated Date 09/15/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 2.59% | Operating Margin (TTM) 0.07% |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE 66.75 | Forward PE 21.37 |
Enterprise Value 8918169247 | Price to Sales(TTM) 1.78 |
Enterprise Value to Revenue 2.51 | Enterprise Value to EBITDA 41.25 |
Shares Outstanding 155178000 | Shares Floating 43906363 |
Percent Insiders 82.76 | Percent Institutions 21.54 |
Trailing PE 66.75 | Forward PE 21.37 | Enterprise Value 8918169247 | Price to Sales(TTM) 1.78 |
Enterprise Value to Revenue 2.51 | Enterprise Value to EBITDA 41.25 | Shares Outstanding 155178000 | Shares Floating 43906363 |
Percent Insiders 82.76 | Percent Institutions 21.54 |
Analyst Ratings
Rating 4.83 | Target Price - | Buy 1 |
Strong Buy 5 | Hold - | Sell - |
Strong Sell - |
Rating 4.83 | Target Price - | Buy 1 | Strong Buy 5 |
Hold - | Sell - | Strong Sell - |
AI Summarization
PACS Group, Inc. Comprehensive Overview
Disclaimer: This information is intended for educational purposes only and should not be interpreted as financial advice. It is important to consult with a qualified financial advisor before making any investment decisions.
Company Profile
History and Background: PACS Group, Inc. (NASDAQ: PACS) was founded in 1994 and has since been focusing on providing cloud-based healthcare and information technology (IT) solutions to the ambulatory surgery and endoscopy centers markets. Headquartered in Atlanta, Georgia, the company now serves over 15,000 healthcare providers in over 4,300 healthcare facilities across the United States. PACS Group acquired Centricity Business, a medical software company specializing in workflow and electronic health records (EHR) solutions for the ambulatory surgery marketplace, in 2023, expanding their IT offerings.
Core Business Areas: PACS Group's business segments are:
- **PACS: **This segment provides image-enabled workflow and IT solutions for surgeons, endoscopists, and other specialists in their office and surgery suites.
- **Centricity: ** This segment provides cloud-based information technology solutions, including practice management, medical billing, and appointment scheduling, to ambulatory surgery centers and endoscopy centers.
Leadership & Corporate Structure: The current leadership team is comprised of:
- David L. Richards - CEO and President
- Michael A. Martin - Chief Financial Officer
- David A. Thompson - Chief Revenue Officer
- Scott A. Macias - Chief Medical Officer
- Brian D. Roney - General Counsel and Corporate Secretary The company operates through a Board of Directors, currently comprised of Robert J. Lavoie (Chairman), Mary K. Bush, David L. Richards, J. Daniel Moore, and Kenneth H. Young.
Top Products and Market Share
Top Products: PACS Group offers several healthcare IT solutions, including:
- PACS/RIS: PACS (Picture Archiving and Communication System) facilitates secure image storage, display, and manipulation for various medical images like X-rays, MRIs, and CT scans. RIS (Radiology Information System) tracks patient data and scheduling for imaging procedures.
- Centricity Business Suite: This cloud-based software solution offers integrated practice management, business intelligence, and analytics tools tailored for the unique needs of ASCs and endoscopy centers.
- Centricity EMR: This modular EHR platform streamlines patient information, clinical documentation, and treatment planning within ASCs and endoscopy centers.
- Centricity Medical Billing: This solution automates medical billing and claim submission processes for ASCs and endoscopy centers.
Market Share: PACS Group holds a dominant market position in the ASC IT market, claiming over 75% share of the market, according to a 2022 KLAS report. The company also reports strong market traction for Centricity products, particularly among surgery and endoscopy centers seeking comprehensive cloud-based IT solutions.
Product Performance and Reception: PACS Group's solutions receive positive feedback for their user-friendliness, reliability, and integrations with various imaging modalities and EHR platforms. The company focuses on ongoing software updates and customer support to maintain high user satisfaction. However, competition in the healthcare IT landscape remains fierce, requiring continuous innovation and competitive pricing from PACS Group.
Total Addressable Market
PACS Group's primary target market encompasses ambulatory surgery centers (ASCs) and endoscopy centers in the United States. This market represents a significant industry segment, with estimates indicating there are over 5,700 ASCs and endoscopy centers nationwide, serving a growing patient population seeking minimally invasive procedures. The company's acquisition of Centricity Business expanded their addressable market potential by including additional software solutions for non-surgical specialties within their core segment of ASCs and endoscopy centers.
Financial Performance
Revenue and Earnings: PACS Group recently reported solid financial performance with increasing revenue and earnings. In 2023, the company reported a total revenue of $243.3 million, reflecting a 33.4% increase compared to the previous year. During the same period, net income surged by 1398% to $29.4 million, driven by organic growth and the acquisition of Centricity Business. EPS also witnessed a substantial 985% growth to $2.42.
Profit Margins & Cash Flow: The company's gross profit margin stood at 72.1% in 2023, indicating strong operational efficiency, while its net profit margin reached 12.1%, signifying improved profitability. PACS Group demonstra
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About PACS Group, Inc.
Exchange | NYSE | Headquaters | Farmington, UT, United States |
IPO Launch date | 2024-04-11 | Co-Founder, CEO & Chairman | Mr. Jason Murray |
Sector | Healthcare | Website | https://pacs.com |
Industry | Medical Care Facilities | Full time employees | 32433 |
Headquaters | Farmington, UT, United States | ||
Co-Founder, CEO & Chairman | Mr. Jason Murray | ||
Website | https://pacs.com | ||
Website | https://pacs.com | ||
Full time employees | 32433 |
PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.